Bulletin
Investor Alert

New York Markets Close in:

Enfusion Inc.

NYS: ENFN

GO
/marketstate/country/us

Market open

 --Real time quotes

Jan 27, 2022, 10:06 a.m.

/zigman2/quotes/230006699/composite

$

12.65

Change

+0.11 +0.88%

Volume

Volume 6,698

Real time quotes

/zigman2/quotes/230006699/composite

Previous close

$ 12.54

$ 12.65

Change

+0.11 +0.88%

Day low

Day high

$12.52

$12.84

Open

52 week low

52 week high

$12.40

$23.21

Open

Insider Actions for Enfusion Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/31/2021 Lawrence E. Leibowitz
Director
5,515   Award at $0 per share. 0
10/31/2021 Kathleen Traynor DeRose
Director
5,515   Award at $0 per share. 0
10/31/2021 Kathleen Traynor DeRose
Director
11,029   Award at $0 per share. 0
10/31/2021 Jan R. Hauser
Director
5,515   Award at $0 per share. 0
10/31/2021 Jan R. Hauser
Director
11,029   Award at $0 per share. 0
10/25/2021 Iconiq Capital LLC
Director
722,707   Acquisition at $17 per share. 12,286,019
10/25/2021 Iconiq Capital LLC
Director
538,887   Acquisition at $17 per share. 9,161,079
10/25/2021 HHLR Advisors Ltd.
647,862   Disposition at $15.9 per share. 10,301,005

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
5 Purchases
0 Sales
38,603
0
Last 6 months
7 Purchases
1 Sales
1,300,197
647,862
Last 12 months
7 Purchases
1 Sales
1,300,197
647,862

Officers and Executives

Mr. Thomas Kim
Chief Executive Officer & Director
Mr. Stephen P. Dorton
Chief Financial Officer
Mr. Dan Groman
Chief Technology Officer
Mr. Steven M. Bachert
Chief Revenue Officer
Mr. Xin Wei Wang
Chief Strategy Officer
Mr. Bradford E. Bernstein
Director
Mr. Tarek Hammoud
Director
Mr. Lawrence E. Leibowitz
Director
Mr. Roy Luo
Director
Mr. Oleg Movchan
Director
Ms. Kathleen Traynor DeRose
Non-Executive Director
Ms. Jan R. Hauser
Non-Executive Director
Ms. Lorelei M. Skillman
Chief Marketing & Communications Officer
Ms. Bronwen Bastone
Chief People Officer
Link to MarketWatch's Slice.